Skip to main content
☰
moat
keep
Markets
News
Screener
Research
Editorials
Pricing
About
⌘K
Sign in
Start free
EUPRAXIA PHARMACEUTICALS INC. (EPRX) stock — financials, valuation and filings | Moatkeep
Companies
/
Nasdaq
/
EPRX
EUPRAXIA PHARMACEUTICALS INC.
EPRX · Nasdaq
$7.25
−1.76%
Close, 2026-10-29
Close, 2026-10-29 · source: Databento · USD · figures not investment advice
+ Alert
★ Watchlist
Overview
News
Valuation
Financials
Reports
Editorials & Research
Business
1M
3M
6M
YTD
1Y
3Y
5Y
10Y
MAX
⤢ Expand
Price
▾
Log
Volume
Events
▾
Window
+149.1%
vs low
+215.2%
vs high
-20.1%
Price
through 2026-10-29
ex-date (0) · fiscal quarter (0)
Dividends: company filings (SEC EDGAR) and the historical exchange record.
State of incorporation
A1
Fiscal year end
Dec 31
Financials · latest year
USD millions
FY2025
Revenue
0
Net Income
-39
FY2024
•••••
•••••
FY2023
•••••
•••••
FY2022
•••••
•••••
Read the full financial statements
Create a free account to see 5 years of financial history
Create a free account
Source: SEC EDGAR (XBRL) · figures in USD millions
View full financials →
Related companies
OCGN
—
Ocugen, Inc.
NAGE
—
Niagen Bioscience, Inc.
LTRX
—
LANTRONIX INC
GEVO
—
Gevo, Inc.
STRT
—
STRATTEC SECURITY CORP
SENS
—
Senseonics Holdings, Inc.
EBS
—
Emergent BioSolutions Inc.
FRD
—
FRIEDMAN INDUSTRIES INC